Journal of Chromatography B 2005-12-05

Metabolism of isometheptene in human urine and analysis by gas chromatography-mass spectrometry in doping control.

Emmanouil Lyris, George Tsiakatouras, Yiannis Angelis, Michael Koupparis, Maria-Helen Spyridaki, Costas Georgakopoulos

Index: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 827(2) , 199-204, (2005)

Full Text: HTML

Abstract

A study of the metabolism of isometheptene, an antispasmodic drug, in man and comparison with heptaminol metabolism, is presented in this paper. Isometheptene and two metabolites were detected in human urine after oral administration of a tablet containing isometheptene mucate. The urine level of the parent drug, which is excreted during the first 24 h, was determined using gas chromatography-mass spectrometry, after alkaline extraction with organic solvent. A minor metabolite of isometheptene was converted to heptaminol in vitro under the acidic hydrolysis conditions used for the screening procedure of stimulants and narcotics in doping control analysis.


Related Compounds

Related Articles:

Double-blind plethysmographic study of venous effects of heptaminol adenosine phosphate in patients with primary varicose veins.

1989-01-01

[Eur. J. Clin. Pharmacol. 37(1) , 37-40, (1989)]

Measurement of lymphatic flow variation by noninvasive method cases of lymphedema.

1992-07-01

[Angiology 43(7) , 567-71, (1992)]

A case of lipomeningocele reported with fluoxetine (and alprazolam, vitamins B1 and B6, heptaminol) prescribed during pregnancy.

1995-01-01

[Eur. J. Obstet. Gynecol. Reprod. Biol. 58(1) , 85-6, (1995)]

Solid-phase column chromatographic and gas chromatographic-mass spectrometric determination of heptaminol in human urine and related pharmacokinetic profiles.

2006-01-01

[J. Anal. Toxicol. 30(6) , 365-9, (2006)]

Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians.

1990-01-01

[Fundam. Clin. Pharmacol. 4(6) , 695-705, (1990)]

More Articles...